title: Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome.
abstract: OBJECTIVE
  To examine the impact of a rooming-in program for infants at risk of neonatal abstinence syndrome (NAS) on the need for pharmacologic treatment and length of hospitalization.
  
  
  METHODS
  Our hospital implemented a rooming-in program for newborns at risk of NAS in June 2013. Previously, standard care was to admit these infants to the neonatal intensive care unit. Charts were reviewed to abstract data on at-risk infants born in the 13-month periods prior and subsequent to implementation of rooming-in (n = 24 and n = 20, respectively) and the groups were compared with the outcomes of interest.
  
  
  RESULTS
  Rooming-in was associated with a reduced need for pharmacologic treatment and shorter length of stay.
  
  
  CONCLUSIONS
  These findings add to an emerging body of evidence on the health care resource utilization benefits associated with rooming-in for infants at risk of NAS. Future studies should evaluate a broader range of outcomes for this model of care.
authors.affiliation: Department of Pediatrics, Queen's University, Kingston, Ontario, Canada.
authors.forename: Sarah
authors.initials: S
authors.lastname: McKnight
authors.affiliation: Department of Pediatrics, Queen's University, Kingston, Ontario, Canada.
authors.forename: Helen
authors.initials: H
authors.lastname: Coo
authors.affiliation: Department of Obstetrics & Gynaecology, Queen's University, Kingston, Ontario, Canada.
authors.forename: Gregory
authors.initials: G
authors.lastname: Davies
authors.affiliation: Pediatrics Program, Kingston General Hospital, Kingston, Ontario, Canada.
authors.forename: Belinda
authors.initials: B
authors.lastname: Holmes
authors.affiliation: Department of Family Medicine, Queen's University, Kingston, Ontario, Canada.
authors.forename: Adam
authors.initials: A
authors.lastname: Newman
authors.affiliation: Pediatrics Program, Kingston General Hospital, Kingston, Ontario, Canada.
authors.forename: Lynn
authors.initials: L
authors.lastname: Newton
authors.affiliation: Department of Pediatrics, Queen's University, Kingston, Ontario, Canada.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Dow
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D001903:Bottle Feeding / Q000706:statistics & numerical data; D001942:Breast Feeding / Q000706:statistics & numerical data; D002170:Canada; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007902:Length of Stay / Q000706:statistics & numerical data*; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009357:Neonatal Abstinence Syndrome / Q000628:therapy*; D058850:Opiate Substitution Treatment / Q000379:methods; D009293:Opioid-Related Disorders / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012306:Risk; D012386:Rooming-in Care / Q000379:methods*; D062606:Tertiary Care Centers; D055815:Young Adult
chemical_list: D000701:Analgesics, Opioid; D008691:Methadone